Scott L. Burrows

Insider Reports History

Location
Waltham, MA
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott L. Burrows:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spyre Therapeutics, Inc. Chief Financial Officer Common Stock 97,994 $1,593,382 $16.26 02 Sep 2025 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 59,115 $209,314 $3.54 06 Mar 2023 Direct
Spyre Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 140,000 09 Jan 2026 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 55,800 02 Mar 2023 Direct

Insider Reports Filed by Scott L. Burrows

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRE Spyre Therapeutics, Inc. 09 Jan 2026 1 $0 4 Chief Financial Officer 13 Jan 2026, 21:27
SYRE Spyre Therapeutics, Inc. 02 Sep 2025 1 -$299,639 4 Chief Financial Officer 03 Sep 2025, 18:53
SYRE Spyre Therapeutics, Inc. 15 Jan 2025 1 $0 4 Chief Financial Officer 17 Jan 2025, 16:36
SYRE Spyre Therapeutics, Inc. 03 Sep 2024 1 -$522,074 4 Chief Financial Officer 05 Sep 2024, 16:04
SYRE Spyre Therapeutics, Inc. 01 Feb 2024 1 $0 4 Chief Financial Officer 02 Feb 2024, 20:27
SYRE Spyre Therapeutics, Inc. 22 Dec 2023 1 $0 4 Chief Financial Officer 22 Dec 2023, 18:00
AGLE Aeglea BioTherapeutics, Inc. 01 Sep 2023 1 $0 4 Chief Financial Officer 05 Sep 2023, 17:10
AGLE Aeglea BioTherapeutics, Inc. 01 Sep 2023 0 $0 3 Chief Financial Officer 05 Sep 2023, 17:06
ARQT Arcutis Biotherapeutics, Inc. 06 Mar 2023 1 -$4,442 4 Chief Financial Officer 08 Mar 2023, 15:29
ARQT Arcutis Biotherapeutics, Inc. 02 Mar 2023 2 $0 4 Chief Financial Officer 06 Mar 2023, 17:58
ARQT Arcutis Biotherapeutics, Inc. 28 Feb 2023 3 -$29,421 4 Chief Financial Officer 02 Mar 2023, 18:05
ARQT Arcutis Biotherapeutics, Inc. 16 Sep 2022 2 +$8,403 4 Chief Financial Officer 20 Sep 2022, 16:37
ARQT Arcutis Biotherapeutics, Inc. 03 Mar 2022 4 -$5,104 4 Chief Financial Officer 07 Mar 2022, 19:49
ARQT Arcutis Biotherapeutics, Inc. 01 Mar 2022 1 -$7,456 4 Chief Financial Officer 03 Mar 2022, 15:17
ARQT Arcutis Biotherapeutics, Inc. 30 Dec 2021 1 $0 4 Chief Financial Officer 04 Jan 2022, 20:05
ARQT Arcutis Biotherapeutics, Inc. 27 Dec 2021 1 -$252,139 4 Chief Financial Officer 28 Dec 2021, 16:00